TACT vs ZTS · rev $28.4M vs P/E 25, rev $2.47B
TransAct Technologies Incorporated (TACT) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
TransAct Technologies Incorporated (TACT) is a computer hardware company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported TACT revenue for 2026-06-30 was $28.4M. Net income was $716.0K. Revenue was up 96.8% from 2026-03-31 to 2026-06-30. TACT currently screens at market cap $49.3M.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
TACT currently screens at market cap $49.3M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the TACT and ZTS stock pages for the full models.
Not investment advice.